Literature DB >> 31058365

GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.

Allison E Cherry1, Juan Jesus Vicente2, Cong Xu1, Richard S Morrison3, Shao-En Ong1, Linda Wordeman2, Nephi Stella1,4.   

Abstract

GPR124 is involved in embryonic development and remains expressed by select organs. The importance of GPR124 during development suggests that its aberrant expression might participate in tumor growth. Here we show that both increases and decreases in GPR124 expression in glioblastoma cells reduce cell proliferation by differentially altering the duration mitotic progression. Using mass spectrometry-based proteomics, we discovered that GPR124 interacts with ch-TOG, a known regulator of both microtubule (MT)-plus-end assembly and mitotic progression. Accordingly, changes in GPR124 expression and ch-TOG similarly affect MT assembly measured by real-time microscopy in cells. Our study describes a novel molecular interaction involving GPR124 and ch-TOG at the plasma membrane that controls glioblastoma cell proliferation by modifying MT assembly rates and controlling the progression of distinct phases of mitosis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  G protein-coupled receptors and microtubules; cell proliferation; glioblastomas

Mesh:

Substances:

Year:  2019        PMID: 31058365      PMCID: PMC6557680          DOI: 10.1002/glia.23628

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  75 in total

1.  Metabotropic glutamate receptor type 1alpha and tubulin assemble into dynamic interacting complexes.

Authors:  F Ciruela; R A McIlhinney
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

2.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

3.  XMAP215 is a processive microtubule polymerase.

Authors:  Gary J Brouhard; Jeffrey H Stear; Tim L Noetzel; Jawdat Al-Bassam; Kazuhisa Kinoshita; Stephen C Harrison; Jonathon Howard; Anthony A Hyman
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

Review 4.  Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure.

Authors:  Jeffrey M Schappi; Aleksandar Krbanjevic; Mark M Rasenick
Journal:  Biochim Biophys Acta       Date:  2013-09-23

5.  Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling.

Authors:  Yulian Zhou; Jeremy Nathans
Journal:  Dev Cell       Date:  2014-10-16       Impact factor: 12.270

6.  G-protein coupled receptor 124 (GPR124) in endothelial cells regulates vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.

Authors:  Y Wang; S-G Cho; X Wu; S Siwko; M Liu
Journal:  Curr Mol Med       Date:  2014-05       Impact factor: 2.222

Review 7.  G protein-coupled receptors as promising cancer targets.

Authors:  Ying Liu; Su An; Richard Ward; Yang Yang; Xiao-Xi Guo; Wei Li; Tian-Rui Xu
Journal:  Cancer Lett       Date:  2016-03-18       Impact factor: 8.679

8.  A microtubule-associated protein from Xenopus eggs that specifically promotes assembly at the plus-end.

Authors:  D L Gard; M W Kirschner
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

9.  Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targets.

Authors:  Marie Fève; Jean-Michel Saliou; Maria Zeniou; Sarah Lennon; Christine Carapito; Jihu Dong; Alain Van Dorsselaer; Marie-Pierre Junier; Hervé Chneiweiss; Sarah Cianférani; Jacques Haiech; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Comparing SILAC- and stable isotope dimethyl-labeling approaches for quantitative proteomics.

Authors:  Ho-Tak Lau; Hyong Won Suh; Martin Golkowski; Shao-En Ong
Journal:  J Proteome Res       Date:  2014-08-12       Impact factor: 4.466

View more
  8 in total

Review 1.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

Review 2.  Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.

Authors:  Trisha Lala; Randy A Hall
Journal:  Physiol Rev       Date:  2022-04-25       Impact factor: 46.500

3.  Defining endogenous TACC3-chTOG-clathrin-GTSE1 interactions at the mitotic spindle using induced relocalization.

Authors:  Ellis L Ryan; James Shelford; Teresa Massam-Wu; Richard Bayliss; Stephen J Royle
Journal:  J Cell Sci       Date:  2021-02-01       Impact factor: 5.285

Review 4.  Adhesion G protein-coupled receptors in glioblastoma.

Authors:  Gabriele Stephan; Niklas Ravn-Boess; Dimitris G Placantonakis
Journal:  Neurooncol Adv       Date:  2021-03-23

5.  Modeling invasion patterns in the glioblastoma battlefield.

Authors:  Martina Conte; Sergio Casas-Tintò; Juan Soler
Journal:  PLoS Comput Biol       Date:  2021-01-29       Impact factor: 4.475

6.  chTOG is a conserved mitotic error correction factor.

Authors:  Jacob A Herman; Matthew P Miller; Sue Biggins
Journal:  Elife       Date:  2020-12-30       Impact factor: 8.140

7.  Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach.

Authors:  Sina Sender; Ahmad Wael Sultan; Daniel Palmer; Dirk Koczan; Anett Sekora; Julia Beck; Ekkehard Schuetz; Leila Taher; Bertram Brenig; Georg Fuellen; Christian Junghanss; Hugo Murua Escobar
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

8.  GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway.

Authors:  Hongxv Wang; Danyu Du; Jianwen Huang; Shuai Wang; Xv He; Shengtao Yuan; Jing Xiao
Journal:  Cancer Manag Res       Date:  2022-03-17       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.